Related Experiment Video

Updated: Feb 7, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

52.1K

[2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease

,

    Zhonghua Nei Ke Za Zhi
    |July 31, 2018
    PubMed

    Insights

    This consensus provides expert guidelines for diagnosing and treating interstitial lung disease (ILD) in patients with connective tissue diseases (CTDs). It standardizes early screening, diagnosis, monitoring, and treatment strategies for improved patient care.

    Area of Science:

    • Rheumatology and Pulmonology
    • Connective Tissue Diseases
    • Interstitial Lung Disease

    Background:

    • Interstitial lung disease (ILD) is a significant complication of connective tissue diseases (CTDs).
    • Establishing expert consensus is crucial for standardizing the diagnosis and treatment of CTD-associated ILD.
    • Current management strategies require optimization for better patient outcomes.

    Purpose of the Study:

    • To develop expert consensus on the diagnosis and treatment of ILD associated with CTDs.
    • To provide evidence-based recommendations for clinical practice in China.
    • To standardize the multidisciplinary approach to managing CTD-ILD.

    Main Methods:

    • A multidisciplinary consensus development panel of 41 experts was convened.
    • Experts included specialists in rheumatology, pulmonology, and radiology.
    • The panel formulated 3 major principles and 7 recommendations through a consensus process.

    Main Results:

    • The consensus addresses early screening, diagnosis, and disease monitoring for CTD-ILD.
    • Recommendations cover immunosuppressive and anti-fibrotic therapies.
    • A treat-to-target approach is emphasized for disease management.

    Conclusions:

    • This consensus aims to guide clinical decision-making for CTD-ILD.
    • Standardized care protocols are expected to improve management of these complex patients.
    • The guidelines are intended for implementation within the Chinese healthcare system.

    Keywords:
    Connective tissue diseaseConsensus statement/guidelinesDiagnosisInterstitial lung diseaseTreatment

    More Related Videos

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease04:44

    Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

    Published on: June 16, 2020

    20.9K
    International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure05:50

    International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

    Published on: March 12, 2020

    14.7K

    Related Concept Videos

    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    1.2K
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    963
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
    518
    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
    544
    Inflammatory Bowel Disease II: Crohn's Disease01:30

    Inflammatory Bowel Disease II: Crohn's Disease

    Introduction
    Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
    Crohn's disease
    Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
    1.1K
    Introduction to Connective Tissues01:11

    Introduction to Connective Tissues

    Connective tissues are one of the four main tissue types in humans that are extensively present in the body. They are characterized by cells embedded in an extracellular matrix (ECM) composed of a ground substance and three main types of protein fibers— collagen, elastic, and reticular fibers. The ground substance of connective tissues can range from a watery and jelly-like consistency to mineralized and hard. The wide variety of cells in the connective tissues include fibroblasts,...
    15.0K